iomarkers are measurable cells, proteins, and/or metabolic yproducts that represent, either directly or indirectly, one or ore processes in a defined biological system or disease tate (2). Because biomarkers reflect health and disease ccording to genetic makeup, gene–gene interactions, gene– nvironmental interactions, and a dynamic interface beween genotype–phenotype relationships (3), one coul...

BACKGROUND Blood-based or urinary biomarkers may play a role in quantifying the future risk of type 2 diabetes (T2D) and in understanding possible aetiological pathways to disease. However, no systematic review has been conducted that has identified and provided an overview of available biomarkers for incident T2D. We aimed to systematically review the associations of biomarkers with risk of de...

metabolomics studies provide useful information about health and disease status. metabolite based investigations on various cancers is a powerful approach to diagnosis, prognosis and therapy of cancer diseases. recently by using advanced analytical techniques such as nmr and ms and its hyphenation methods, global metabolic profiling of diseases has been possible. it is predictable that internat...

breast cancer (bc) accounts for one of the major health problems around the world. since the diagnosis process can have great effect on therapy outcomes, we studied the biomarkers specific to breast tumors stage i based on examining different iranian patients. cases from different stages were examined to discover their highly expressed proteins. in addition, pathologic evaluations were performe...

metabolome analysis is used to evaluate the characteristics and interactions of low molecular weight metabolites under a specific set of conditions. in cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease (nafld) and non-alcoholic steatotic hepatitis (nash) the  liver  does not function thoroughly due to long-term damage. unfortunately the early detection of cirrhosis, hcc, na...

BACKGROUND New renal biomarkers measured in urine promise to increase specificity for risk stratification and early diagnosis of acute kidney injury (AKI) but concomitantly may be altered by urine concentration effects and chronic renal insufficiency. This study therefore directly compared the performance of AKI biomarkers in urine and plasma. METHODS This single-center, prospective cohort st...